Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Iida

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Scientific Reports|April 23, 2024
Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysisSeiya Takano, Natsuo Tomita, Mayu Kuno, et al.
Leukemia & Lymphoma|May 6, 2020
Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphomaKenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, et al.
International Journal of Hematology|January 31, 2018
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma ForumYayoi Matsumura-Kimoto, Junya Kuroda, Hitomi Kaneko, et al.
International Journal of Hematology|September 5, 2023
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma ForumYuji Shimura, Hirohiko Shibayama, Aya Nakaya, et al.
International Journal of Hematology|August 13, 2020
Retrospective analysis of plasmacytoma in Kansai Myeloma Forum RegistryAya Nakaya, Hirokazu Tanaka, Hideo Yagi, et al.
Therapeutic Advances in Hematology|December 19, 2022
Monocyte or white blood cell counts and β<sub>2</sub> microglobulin predict the durable efficacy of daratumumab with lenalidomideYutaka Shimazu, Junya Kanda, Hitomi Kaneko, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Scientific Reports|April 23, 2024
Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysisSeiya Takano, Natsuo Tomita, Mayu Kuno, et al.
Leukemia & Lymphoma|May 6, 2020
Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphomaKenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, et al.
International Journal of Hematology|January 31, 2018
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma ForumYayoi Matsumura-Kimoto, Junya Kuroda, Hitomi Kaneko, et al.
International Journal of Hematology|September 5, 2023
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma ForumYuji Shimura, Hirohiko Shibayama, Aya Nakaya, et al.
International Journal of Hematology|August 13, 2020
Retrospective analysis of plasmacytoma in Kansai Myeloma Forum RegistryAya Nakaya, Hirokazu Tanaka, Hideo Yagi, et al.
Therapeutic Advances in Hematology|December 19, 2022
Monocyte or white blood cell counts and β<sub>2</sub> microglobulin predict the durable efficacy of daratumumab with lenalidomideYutaka Shimazu, Junya Kanda, Hitomi Kaneko, et al.
Pageof 4